Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives

Multidrug-resistant tuberculosis (MDR-TB) is on the rise, and is difficult to treat. The approval of two new drugs, bedaquiline and delamanid, and growing evidence for the use of linezolid, offer renewed hope for addressing MDR-TB. However, access to these medicines remains a significant challenge....

Full description

Bibliographic Details
Main Authors: Erica Lessem, Helen Cox, Colleen Daniels, Jennifer Furin, Lindsay McKenna, Carole D. Mitnick, Thato Mosidi, Caitlin Reed, Barbara Seaworth, Jonathan Stillo, Phumeza Tisile, Dalene von Delft
Format: Article
Language:English
Published: Elsevier 2015-03-01
Series:International Journal of Infectious Diseases
Subjects:
Tuberculosis
Multidrug-resistant tuberculosis
Drugs
Access
Compassionate use
Community
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971214017299

Internet

http://www.sciencedirect.com/science/article/pii/S1201971214017299

Similar Items